Albumin Market is Anticipated to Reach Around US$ 8.2 Billion By 2028 | Growth Rate (CAGR) of 6.05%

According to IMARC Group latest report titled “Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on albumin market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global albumin market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.05% during 2023-2028.

Albumin is a form of protein that is generally found in the blood and bodily fluids. It is synthesized in the liver and is the most abundant protein present in the blood, accounting for significant protein concentration. It is essential for maintaining osmotic pressure and transporting substances, such as hormones, drugs, fatty acids, and toxins throughout the body. It aids in regulating blood volume and the pH of the body. Additionally, it helps to keep the body hydrated by absorbing water and maintaining the balance of electrolytes. It also plays an important role in the immune system, helping to fight against bacteria and viruses. Albumin levels can be tested with a simple blood test to help diagnose and monitor numerous medical conditions. Low albumin levels can indicate dehydration, malnutrition, certain types of liver and kidney diseases, and other medical conditions. High albumin levels may indicate an infection, inflammation, or some types of cancer.

Request to Get the Free Sample Report: https://www.imarcgroup.com/albumin-market/requestsample

Market Trends:

The growing prevalence of chronic diseases among the masses majorly drives the global market. With the increasing prevalence of chronic diseases, including diabetes, obesity, and cardiovascular diseases, has propelled the use of albumin as a therapeutic measure. Albumin is widely utilized to treat conditions, such as hypoalbuminemia, edema, and protein-losing enteropathy, which are common in individuals suffering from chronic diseases, is impacting the market. Along with this, the rising awareness regarding the benefits of albumin is escalating its recommendations among healthcare professionals, further impacting the demand. In addition, the widespread adoption of albumin in the production of plasma, cryoprecipitate, and thawed plasma is also positively influencing the market. Moreover, the extensive utilization of albumin in research conducted in the fields of biotechnology, drug discovery, and diagnostics is creating a positive market outlook. Some of the other factors driving the market include the introduction of albumin-based nanoparticles and emerging healthcare industry.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/albumin-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Albumedix Ltd
  • Biotest AG
  • Celgene Corporation (Bristol-Myers Squibb Company)
  • CSL Limited
  • Grifols SA
  • HiMedia Laboratories
  • Medxbio Pte Ltd
  • Merck KGaA
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Ventria Bioscience Inc

Albumin Market Segmentation:

Our report has categorized the market based on region, product, application and end use industry.

Breakup by Product:

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

Breakup by Application:

  • Therapeutics
  • Drug Formulation and Vaccine
  • Component of Media
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Popular posts from this blog

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery